Research output per year
Research output per year
Personal profile
Headline
PROFESSOR | Medicine, Hematology and Medical Oncology
Biography
Dr. Tiersten is a Professor in the Division of Hematology and Medical Oncology and a member of the Breast Cancer Medical Oncology Program. Dr. Tiersten sees patients in the Dubin Breast Center. She works collaboratively with Mount Sinai breast surgeons, radiation oncologists, radiologists, and other related subspecialists to provide care to breast cancer patients and conduct breast cancer research. Dr. Tiersten has extensive experience participating clinical trials, as well as being the Principal Investigator for national studies.
Fingerprint
Dive into the research topics where Amy Tiersten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: A National Cancer Data Base analysis
Patel, R. B., Sheng, T., Diniz, M. A., Sparano, J. A. & Tiersten, A., 1 Mar 2025, In: Cancer. 131, 5, e35771.Research output: Contribution to journal › Article › peer-review
-
Low Dose Tamoxifen for Breast Cancer Prevention: A Real-World Experience
Patel, R., Jin, C., Jaber, D., Casasanta, N., Jain, M., Fu, W., Wu, C., Moshier, E. & Tiersten, A., Apr 2025, In: Clinical Breast Cancer. 25, 3, p. 283-290 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Oral Cannabis for Taxane-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Study
Haney, M., Choo, T. H., Tiersten, A., Levin, F. R., Grassetti, A., DeSilva, N., Arout, C. A. & Martinez, D., 2025, (Accepted/In press) In: Cannabis and Cannabinoid Research.Research output: Contribution to journal › Article › peer-review
-
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
Saxena, M., Marron, T. U., Kodysh, J., Finnigan, J. P., Onkar, S., Kaminska, A., Tuballes, K., Guo, R., Sabado, R. L., Meseck, M., O’donnell, T. J., Sebra, R. P., Parekh, S., Galsky, M. D., Blasquez, A., Gimenez, G., Bicak, M., Bozkus, C. C., Delbeau-Zagelbaum, D. & Rodriguez, D. & 17 others, , 1 May 2025, In: Cancer Discovery. 15, 5, p. 931-947 17 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors
Montgomery, G. H., Schnur, J. B., Tiersten, A., Benck, K. & Erblich, J., 2024, (Accepted/In press) In: Psychology of Consciousness: Theory Research, and Practice.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Data on Breast Cancer Reported by Researchers at Icahn School of Medicine at Mount Sinai (Low Dose Tamoxifen for Breast Cancer Prevention: a Real-world Experience)
Moshier, E. & Tiersten, A.
11/04/25
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai in the Area of Breast Cancer Reported (Impact of Race/ethnicity On Mammaprint Genomic Assay Risk and Prognosis In Early Breast Cancer: a National Cancer Data Base Analysis)
Tiersten, A., Diniz, M. A. & Sparano, J.
24/03/25
1 item of Media coverage
Press/Media
-
Woman, 27, is diagnosed with breast cancer just 2 weeks before her sister, 32, receives the same diagnosis
7/01/25
1 item of Media coverage
Press/Media
-
Woman, 27, is diagnosed with breast cancer just 2 weeks before her sister, 32, receives the same diagnosis
7/01/25
2 items of Media coverage
Press/Media
-
Woman, 27, is diagnosed with breast cancer just 2 weeks before her sister, 32, receives the same diagnosis
7/01/25
1 item of Media coverage
Press/Media